| scholarly article | Q13442814 |
| P50 | author | Shahin Ayazi | Q37829826 |
| Jesse L Costales | Q59221425 | ||
| P2093 | author name string | Florian Augustin | |
| Arzu Oezcelik | |||
| Joerg Zehetner | |||
| Jeffrey A. Hagen | |||
| Steven R. DeMeester | |||
| Tom R. DeMeester | |||
| Helen J. Sohn | |||
| John C. Lipham | |||
| P2860 | cites work | Biology of gastroesophageal reflux disease: pathophysiology relating to medical and surgical treatment | Q33540297 |
| The lower esophagus lined by columnar epithelium | Q34241534 | ||
| Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy | Q34870287 | ||
| Are screening and surveillance for Barrett's oesophagus really worthwhile? | Q35790568 | ||
| Surveillance of Barrett's oesophagus: is it worthwhile? | Q37083842 | ||
| Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review | Q37379015 | ||
| Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis | Q37619801 | ||
| Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery | Q38431822 | ||
| Long-term outcome of antireflux surgery in patients with Barrett's esophagus | Q39414337 | ||
| Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus | Q40304345 | ||
| The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus | Q40860340 | ||
| An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus. | Q43586884 | ||
| Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole | Q43619417 | ||
| Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized | Q43661240 | ||
| Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus | Q44342929 | ||
| Barrett’s Esophagus Can and Does Regress After Antireflux Surgery: A Study of Prevalence and Predictive Features | Q44528666 | ||
| Esophageal pH exposure and epithelial cell differentiation | Q46489965 | ||
| Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough | Q46582064 | ||
| Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery | Q47581140 | ||
| The mutagenic potential of duodenoesophageal reflux. | Q50486949 | ||
| Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. | Q50713853 | ||
| Differential molecular changes in patients with asymptomatic long-segment Barrett's esophagus treated by antireflux surgery or medical therapy. | Q51754910 | ||
| The risk of esophageal adenocarcinoma after antireflux surgery. | Q53348033 | ||
| Is Esophageal Adenocarcinoma Occurring Late After Antireflux Surgery Due to Persistent Postoperative Reflux? | Q58204642 | ||
| Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery | Q58204799 | ||
| The lower esophageal sphincter in health and disease | Q68264456 | ||
| Bile acid accumulation by rabbit esophageal mucosa | Q69616554 | ||
| Gastric mucosal toxicity of duodenal juice constituents in the rat. Acute studies using ex vivo rat gastric chamber model | Q72786740 | ||
| Barrett's esophagus | Q74252155 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Barrett's esophagus | Q808892 |
| P304 | page(s) | 1483-1491 | |
| P577 | publication date | 2010-09-08 | |
| P1433 | published in | Journal of Gastrointestinal Surgery | Q15764393 |
| P1476 | title | Long-term follow-up after anti-reflux surgery in patients with Barrett's esophagus | |
| Long-term Follow-up After Anti-reflux Surgery in Patients with Barrett’s Esophagus | |||
| P478 | volume | 14 |
| Q38210074 | Antireflux surgery for dysplastic Barrett |
| Q27332349 | BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia |
| Q46396452 | Barrett's esophagus after resection of the gastroesophageal junction: effects of concomitant fundoplication |
| Q57546193 | Barrett's esophagus: surgical treatments |
| Q34380645 | British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus |
| Q38088328 | Endoscopic resection (endoscopic submucosal dissection/endoscopic mucosal resection) for superficial Barrett's esophageal cancer |
| Q38001289 | Endotherapy for Barrett's esophagus |
| Q26769068 | Esophageal surgery in minimally invasive era |
| Q48034030 | Feasibility, safety, and short-term efficacy of the laparoscopic Nissen-Hill hybrid repair |
| Q37967701 | Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions |
| Q45746046 | Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry |
| Q90481918 | Regression of intestinal metaplasia following magnetic sphincter augmentation device placement |
| Q35256054 | Surgical treatments for esophageal cancers. |
| Q38220732 | The impact of laparoscopic anti-reflux surgery in patients with Barrett's esophagus |
Search more.